Health Risks from Philips CPAP Foam: What Years of Toxic Exposure Can Do
The PE-PUR foam in recalled Philips CPAP devices released carcinogenic chemicals and physical particles directly into users' airways — nightly, for years. Here's what that means for your health.
Important: This page provides general information about health risks associated with the Philips recall. It is not medical advice. If you have health concerns related to your CPAP use, consult a physician. If you believe your health conditions may be related to a recalled device, consult an attorney about your legal rights.
What Was Being Inhaled
When the PE-PUR foam in Philips CPAP devices degrades, it releases two categories of harmful material:
1. Physical Particles
Visible black or dark fragments of degraded foam can enter the airway tubing and mask, then be inhaled directly into the lungs. Users reported finding black particles in their masks, tubing, and humidifier chambers. These particles can cause physical respiratory irritation and, with chronic exposure, more serious damage.
2. Chemical Off-Gassing (VOCs)
As the foam degrades, it releases volatile organic compounds (VOCs) and other chemicals into the pressurized air stream. Testing identified compounds including:
- Formaldehyde — classified as a known human carcinogen (Group 1) by the International Agency for Research on Cancer (IARC)
- Diethylene glycol — toxic compound associated with kidney damage
- Phenol — toxic with respiratory, cardiovascular, and neurological effects
- Toluene diisocyanate (TDI) — respiratory sensitizer and potential carcinogen
- Other volatile compounds and degradation byproducts
Cancers Linked to Foam Exposure
Cancer Types in the Settlement
- Lung Cancer — The respiratory tract is the direct exposure pathway; lung cancer has a strong association with inhaled carcinogens
- Kidney Cancer (Renal Cell Carcinoma) — Diethylene glycol and other compounds metabolized through the kidneys; kidney cancer is a prioritized injury category in the settlement
- Liver Cancer (Hepatocellular Carcinoma) — The liver processes many of the chemical compounds released by foam degradation
- Throat and Laryngeal Cancer — Direct exposure through the upper airway
- Nasal and Sinus Cancer — Foam particles and gases can deposit in nasal passages and sinus cavities
- Bladder Cancer — Chemical compounds excreted through the urinary system
Respiratory Conditions
Non-Cancer Respiratory Injuries
- Reactive Airway Dysfunction Syndrome (RADS)
- COPD exacerbation — Foam exposure can worsen pre-existing chronic obstructive pulmonary disease
- Asthma worsening
- Pneumonia — Repeated lung insult from particulate inhalation
- Pulmonary fibrosis — Scarring of lung tissue from chronic particle exposure
- Respiratory tract irritation — Coughing, wheezing, shortness of breath
- Pulmonary embolism — Blood clots in the lungs
Other Health Conditions
- Chronic sinusitis — Persistent sinus inflammation and infections
- Headaches — Neurological effects from chemical exposure
- Neurological effects — Some compounds have documented neurotoxic properties
- Kidney damage — Non-cancerous renal injury from diethylene glycol and other nephrotoxic compounds
- Liver damage — Hepatotoxic compound exposure
- Cardiovascular effects — Some exposed chemicals have cardiovascular implications
- Irritation of eyes, nose, and throat
- Nausea, dizziness — Acute effects from chemical off-gassing
Why the Exposure Was So Serious
Several factors made the Philips CPAP foam exposure particularly harmful:
- Nightly exposure: CPAP users sleep with the device 6–8 hours per night — chronic, repeated exposure to any toxin dramatically increases health risk compared to single or occasional exposure
- Direct airway delivery: The CPAP machine pressurizes and delivers air directly into the user's airway under positive pressure — ensuring any contaminated air reached deep into the lungs
- Duration: Many users had been using their devices for years before the recall — some for a decade or more
- Heat and humidity acceleration: Heated humidifiers (common CPAP accessories) and warm sleeping environments accelerate PE-PUR foam degradation — increasing the release rate of particles and gases
- Ozone cleaning devices: Aftermarket ozone-based CPAP cleaners (which Philips did not recommend) further accelerated foam degradation
The 116,000+ FDA Adverse Event Reports
The scale of adverse event reporting to the FDA is extraordinary. More than 116,000 reports were filed — representing one of the largest adverse event reporting events in FDA history for a single device recall. These reports document:
- Cancer diagnoses temporally associated with recalled device use
- Respiratory injuries and hospitalizations
- Physical findings of black particles in devices, masks, and airways
- 561 reported deaths (though causation in each case requires individual analysis)
The Discovery Problem
One of the most significant challenges for affected users is that many health conditions developed slowly over years of exposure. Unlike an acute injury, carcinogen-related cancers and chronic respiratory damage can take years to manifest — and once they do, patients and physicians often don't immediately connect them to CPAP use.
This is why the discovery rule is so important in this litigation. Your statute of limitations may start from when you discovered (or reasonably should have discovered) that your health condition was connected to your recalled Philips device — which for many users was June 2021 or later.
Experienced Any of These Health Conditions While Using a Philips CPAP?
If you used a recalled device and developed cancer, respiratory damage, or other health conditions, you may qualify for the personal injury settlement track. A free eligibility check takes 2 minutes.
Check My Personal Injury Eligibility →